Pearl Therapeutics (Redwood City, CA), a clinical-stage pharmaceutical company focused on the development of therapeutics for respiratory diseases, closed a $65M Series D financing. Participants include Vatera Healthcare Partners, 5AM Ventures, Clarus Ventures and New Leaf Ventures.

Collective IP | The World’s Largest Technology Transfer Office Marketplace

Providing Unrivaled Comprehensive and Accurate Access to Humankinds Most Valuable and Transformative Assets

Receive Collective IP Account Access HERE